Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Mod Pathol. 2019 Nov 04;:
J Urol. 2019 Oct 30;:10109701JU0000612396093094f
Methylation markers in prostate biopsies are prognosticators for late biochemical recurrence and therapy after surgery in prostate cancer patients.
J Mol Diagn. 2019 Oct 09;:
Nat Med. 2019 Oct 07;:
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
Eur Urol. 2019 Oct 03;:
An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients.
Urol Oncol. 2019 Sep 24;:
Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
Eur Urol. 2019 Aug 19;:
Imaging and T Category for Prostate Cancer in the 8th Edition of the Union for International Cancer Control TNM Classification.
Eur Urol Oncol. 2019 Jul 12;:
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.
PLoS Med. 2019 Jul;16(7):e1002847
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.
Eur Urol Oncol. 2019 May;2(3):333-336